跳至主要内容
临床试验/CTRI/2023/05/052601
CTRI/2023/05/052601尚未招募2 期

TO DETERMINE THE CARDIOVASCULAR EFFECT OF CINNAMON CAPSULES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSIONA SINGLE-BLINDED RANDOMIZED CONTROL TRIAL(PILOT STUDY)

Ajinkya Mukund Rahatgaonkar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •Inclusion criteria
  • •Age 30-60 years
  • •Patients with type 2 diabetes mellitus based on ADA criteria.
  • •Patient with Hypertension
  • •Patients taking Oral hypoglycemic agents.
  • •HbA1C: > 7

排除标准

  • •Patient with prior history of an allergy to cinnamon
  • •Alcoholic liver disease (ALD), cirrhosis
  • •On insulin therapy
  • •Raised baseline serum creatinine levels ( >1.5 mg/dl in men or > 1.2 mg/dl in women)
  • •Lactation, pregnancy
  • •Patients with symptoms suggestive of peptic ulcer disease and those with a past history of peptic ulceration
  • •Any malignancy
  • •Patients with unrelated chronic illnesses and infections like Tuberculosis
  • •Patients with cardiac, liver, or respiratory failure.
  • •Patients with bleeding disorders and who are taking coumarin derivatives (e.g., warfarin)
  • •Patients diagnosed with Acute coronary syndrome (CAD- Prior history of MI, angina)

研究者

发起方
Ajinkya Mukund Rahatgaonkar

相似试验